Pueraria isoflavone capsule

From the paper

Abstract

The invention discloses a pueraria isoflavone capsule (or a Hu's Besser capsule). The capsule is prepared by the following components in parts by weight: 1 part of Panax Notoginsenosides, 1 part of radix salviae miltiorrhizae extract, 1 part of ligustrazine, 1 part of kudzu root extract, 0.5 part of tea polyphenol and 1 part of Grifola frondosa extract. The components are combined together to make the effect of each component to generate a synergistic effect to achieve the effect of lowering blood viscosity, reducing blood fat and preventing cardio-cerebral blood vessels from being stiffened and infarcted. The pueraria isoflavone capsule can be used for treating serious diseases influencing the health of the old and lowering the quality of life of the old, such as Alzheimer diseases, hypophrenia caused by cerebral thrombosis, diabetes mellitus, senile benign hypophrenia and the like. Proved by a large number of clinical effect observation tests, through taking effective dose of pueraria isoflavone capsule, patients with mild-moderate dementia can be recovered with self-care ability after taking the capsule for 3 months, and the serious disease of Parkinson's disease and the like can be cured in 3-4 months.